Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Occupational and Environmental Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1097/00043764-199608000-00002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Global REACH 2018: Influence of excessive erythrocytosis on coagulation and fibrinolytic factors in Andean highlanders

  2021cites this paper
• Evaluation of coagulation parameters in patients with parathyroid adenoma

  2020cites this paper
• Investigation of Microalbuminuria Level in Complex Pregnancies with Idiopathic Intrauterine Growth Retardation İdiopatik İntrauterin Gelişme Geriliği İle Komplike Gebeliklerde Mikroalbuminüri Düzeyinin Araştırılması

  2020cites this paper
• The impact of acute exercise on factor VIII in young e-cigarette smokers

  2020influential citation
• Association of Coronary Heart Disease and CRP - as a Noble Marker of Inflammation - A Case Control Study.

  2019cites this paper
• Effects of long-term exposure to an extremely low frequency magnetic field (15 µT) on selected blood coagulation variables in OF1 mice.

  2019cites this paper
• C-Reactive Protein Levels and Its Correlation with Infections, Mortality and Organ Failure in Critically ILL Patients

  2018cites this paper
• A Study of Prognostic Value of Hs-CRP and Fibrinogen in Patients of Unstable Angina

  2018influential citation
• Relationship between Neutrophil-to-lymphocyte Ratio and the Severity of Coronary Artery Disease in Patients Undergoing Cardiac Catheterization

  2018cites this paper
• The relationship between ABO blood types and development of cerebral venous sinus thrombosis

  2017cites this paper
• Interplay between PAPP-A, inflammation and adiposity in patients with angiographically proven acute coronary syndrome (ACS)

  2017cites this paper
• Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention

  2017cites this paper
• Age-related alterations in the level and expression pattern of Von Willebrand Factor (VWF)

  2017cites this paper
• Biology of C Reactive Protein in Health and Disease

  2016cites this paper
• Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention.

  2016cites this paper
• Impact of post-laparoscopic sleeve gastrectomy weight loss on C-reactive protein, lipid profile and CA-125 in morbidly obese women

  2015cites this paper
• Evaluation of Hs-CRP Levels and Interleukin 18 (-137G/C) Promoter Polymorphism in Risk Prediction of Coronary Artery Disease in First Degree Relatives

  2015cites this paper
• Anti-inflammatory effects of gastric bypass surgery and their association with improvement in metabolic profile

  2015cites this paper
• SERUM MAGNESIUM IN ACUTE MYOCARDIAL INFARCTION

  2015cites this paper
• Modeling Risk Convergence for European Financial Markets

  2014cites this paper
• Fibrinogen and Coronary Artery Disease - A Review

  2014cites this paper
• The Effect of Political Risk on Foreign Direct Investment: The Case of Algeria

  2014cites this paper
• Study of Plasma Fibrinogen in Acute Myocardial Infarction

  2013influential citation
• SERVICIOS DE SALUD DE VERACRUZ HOSPITAL REGIONAL DE ALTA ESPECIALIDAD DE VERACRUZ JEFATURA DE ENSEÑANZA E INVESTIGACIÓN COORDINACIÓN DE INVESTIGACIÓN

  2013cites this paper
• Prothrombotic factors and the risk of myocardial infarction and ischaemic stroke in young women : differences similarities and implications

  2013cites this paper
• Microfluidic-Based In-Situ Functionalization for Detection of Proteins in Heterogeneous Immunoassays

  2013cites this paper
• Significant Association between Serum Interleukin-6 and Helicobacter pylori Antibody Levels among H. pylori-Positive Japanese Adults

  2013cites this paper
• A Label-Free Biosensor for Heat Shock Protein 70 Using Localized Surface Plasmon Resonance

  2012cites this paper
• Smoking, von Willebrand factor and ADAMTS-13 in healthy males

  2012cites this paper
• Plasminogen Activator Inhibitor-1, Fibrinogen, and Lung Function in Adolescents with Asthma and Obesity

  2012cites this paper
• Serum trace metal and ceruloplasmin variability in individuals treated for pulmonary tuberculosis.

  2011cites this paper
• Article in press-uncorrected proof Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects

  2011cites this paper
• HS-CRP LEVELS IN MYOCARDIAL INFARCTION PATIENTS IN RELATION TO CARDIAC

  2011cites this paper
• Comparison of hot and cold spell effects on cardiovascular mortality in individual population groups in the Czech Republic

  2011cites this paper
• [Coronary thrombosis with normal epicardial coronary arteries].

  2011cites this paper
• A STUDY OF C-REACTIVE PROTEIN AND ITS RELATIONSHIP WITH CHD AND LIPID METABOLISM Research Article

  2011cites this paper
• Statins and inflammation: an update

  2010cites this paper
• STUDY OF C-REACTIVE PROTEIN AND SOME SMALL ANTIOXIDANT MOLECULE LEVELS IN CORONARY ARTERY DISEASE (CAD)

  2010cites this paper
• Marcadores en los síndromes coronarios agudos

  2010cites this paper
• Effects of climatic temperature stress on cardiovascular diseases.

  2010cites this paper
• CRP and the risk of atherosclerotic events

  2009cites this paper
• Cardiovascular Medications: Pharmacokinetics and Pharmacodynamics

  2009cites this paper
• El fibrinógeno como factor de riesgo de enfermedad aterotrombótica

  2009cites this paper
• the prognostic significance of C-reactive protein as an independent predictor for coronary events in Patients presenting with chest pain

  2009cites this paper
• The effect of weight reduction diet on C-reactive protein level in obese-adult subjects.

  2009cites this paper
• A Study on Metabolic Syndrome in Young Ischemic Stroke

  2009cites this paper
• Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study.

  2009cites this paper
• ABO blood group distribution and major cardiovascular risk factors in patients with acute myocardial infarction

  2008cites this paper
• n 3 Fatty acids and cardiovascular disease : mechanisms underlying beneficial effects 1 – 4

  2008cites this paper
• Relación del fibrinógeno con factores de riesgo cardiovascular en hombres aparentemente sanos de Maracaibo, Venezuela

  2008cites this paper
• The Relationship Between C-Reactive Protein and Diastolic Function of the Left Ventricle in Patients with Acute Myocardial Infarction

  2008cites this paper
• Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients.

  2008cites this paper
• Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.

  2008cites this paper
• Relationship of fibrinogen with arterial stiffness and wave reflections

  2007cites this paper
• ABO(H) blood groups and vascular disease: a systematic review and meta‐analysis

  2007cites this paper
• Ankle—brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort

  2007cites this paper
• Vascular Endothelial Cell Function and Thrombosis

  2007cites this paper
• Testosterone deficiency and the metabolic syndrome

  2007cites this paper
• Changes in fibrinolytic activity after angiotensin II receptor blockade in therapy‐resistant hypertensive patients

  2007cites this paper
• The Role Of von Willebrand Factor In Hemorrhagic And Thrombotic Disorders

  2007cites this paper
• Diabetes mellitus as a prothrombotic condition

  2007cites this paper
• Turmeric Reverses Fibrinogen Spice Lowers Biomarker of Aging and Important Cardiovascular Risk Factor

  2007cites this paper
• Stable angina – who needs revascularisation?

  2007cites this paper
• The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women

  2006cites this paper
• Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease

  2006cites this paper
• Fibrinolytic dysfunction in insulin‐resistant women with previous gestational diabetes

  2006cites this paper
• Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage

  2006cites this paper
• Vascular endothelial and myogenic function in renal disease

  2006cites this paper
• In-Hospital and Long-Term Prognostic Value of Fibrinogen, CRP, and IL-6 Levels in Patients with Acute Myocardial Infarction Treated with Thrombolysis

  2006cites this paper
• Polymorphismus Phe/Tyr 2561 im Von-Willebrand-Faktor-Gen als Risikofaktor für Myokardinfarkt und koronare Herzkrankheit

  2006cites this paper
• von Willebrand factor, endothelial dysfunction, and cardiovascular disease

  2006cites this paper
• Preoperative serum fibrinogen as a predictor of myocardial infarction in the surgical myocardial revascularization.

  2006cites this paper
• Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes

  2006cites this paper
• Vascular endothelial and myogenic function in renal disease

  2006cites this paper
• The 80th anniversary of von Willebrand's disease: history, management and research

  2006cites this paper
• PRACTITIONER SECTION - METABOLIC SYNDROME

  2006cites this paper
• Quyyumi Steps Women ’ s Ischemia Syndrome Evaluation ( WISE ) Study and Future Research Women and Ischemic Heart Disease : Pathophysiologic Implications

  2006cites this paper
• Hemostatic abnormalities associated with obesity and the metabolic syndrome

  2005cites this paper
• Inflammation and Endothelial Function: Direct Vascular Effects of Human C-Reactive Protein on Nitric Oxide Bioavailability

  2005cites this paper
• C-reactive protein and enhancement of tissue damage : a potential therapeutic target

  2005cites this paper
• CRP or not CRP? That is the question.

  2005cites this paper
• Efecto de dosis máximas de atorvastatina en la inflamación, la trombogénesis y la función fibrinolítica en pacientes con cardiopatía isquémica de alto riesgo

  2005cites this paper
• Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study

  2005cites this paper
• Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions

  2005cites this paper
• The effect of multi‐factorial intervention on plasma von Willebrand factor, soluble E‐selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease

  2005cites this paper
• Anticoagulation effect of estroprogesterone therapy in women in menopausal period

  2005cites this paper
• Markers of inflammation and their clinical significance.

  2005cites this paper
• Enhancement of the coagulation system in spontaneously hypertensive and hyperlipidemic rats.

  2005cites this paper
• Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximisation study (BRUM)

  2005cites this paper
• Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new ‘vascular triad’

  2004cites this paper
• Bi-directional modulation of AMPA receptor unitary conductance by synaptic activity

  2004cites this paper
• Comparison of complete and incomplete revascularization in CABG-patients with severely impaired left ventricular function (LVF)

  2004cites this paper
• New Clinical Markers Predictive of Cardiovascular Disease: The Role of Inflammatory Mediators

  2004cites this paper
• C-Reactive Protein as a Marker for Cardiovascular Disease

  2004cites this paper
• Are we content with lowering blood pressure alone, or should we be asking something more from the antihypertensive drugs we use?: effects of antihypertensive agents on fibrinolytic function

  2004cites this paper
• Hemostatic variables and ischemic cardiovascular disease: Do we need a concerted effort for more profitable future clinical investigations?

  2004cites this paper
• PERTINENT—PERindopril–Thrombosis, InflammatioN, Endothelial Dysfunction and Neurohormonal Activation Trial: A Sub-Study of the EUROPA Study

  2004cites this paper
• The Efficacy and Safety of the New Heparin‐induced Extracorporeal Low‐density Lipoprotein Precipitation System (Plasmat Futura) in Comparison with the Currently used System (Plasmat Secura)

  2004cites this paper
• Role of C-Reactive Protein in Cardiovascular Disease

  2004cites this paper
• Role of thrombotic and fibrinolytic factors in acute coronary syndromes.

  2004cites this paper